U.S. flag

An official website of the United States government

NM_001165963.4(SCN1A):c.5066T>C (p.Met1689Thr) AND Early infantile epileptic encephalopathy with suppression bursts

Clinical significance:Uncertain significance (Last evaluated: Sep 1, 2021)

Review status:1 star out of maximum of 4 stars

criteria provided, single submitter

Based on:
1 submission [Details]
Record status:

Allele description [Variation Report for NM_001165963.4(SCN1A):c.5066T>C (p.Met1689Thr)]

NM_001165963.4(SCN1A):c.5066T>C (p.Met1689Thr)

SCN1A:sodium voltage-gated channel alpha subunit 1 [Gene - OMIM - HGNC]
LOC102724058:uncharacterized LOC102724058 [Gene]
Variant type:
single nucleotide variant
Cytogenetic location:
Genomic location:
Preferred name:
NM_001165963.4(SCN1A):c.5066T>C (p.Met1689Thr)
  • NC_000002.12:g.165992209A>G
  • NG_011906.1:g.86431T>C
  • NM_001165963.4:c.5066T>CMANE SELECT
  • NM_001165964.3:c.4982T>C
  • NM_001202435.3:c.5066T>C
  • NM_001353948.2:c.5066T>C
  • NM_001353949.2:c.5033T>C
  • NM_001353950.2:c.5033T>C
  • NM_001353951.2:c.5033T>C
  • NM_001353952.2:c.5033T>C
  • NM_001353954.2:c.5030T>C
  • NM_001353955.2:c.5030T>C
  • NM_001353957.2:c.4982T>C
  • NM_001353958.2:c.4982T>C
  • NM_001353960.2:c.4979T>C
  • NM_001353961.2:c.2624T>C
  • NM_006920.6:c.5033T>C
  • NP_001159435.1:p.Met1689Thr
  • NP_001159436.1:p.Met1661Thr
  • NP_001189364.1:p.Met1689Thr
  • NP_001340877.1:p.Met1689Thr
  • NP_001340878.1:p.Met1678Thr
  • NP_001340879.1:p.Met1678Thr
  • NP_001340880.1:p.Met1678Thr
  • NP_001340881.1:p.Met1678Thr
  • NP_001340883.1:p.Met1677Thr
  • NP_001340884.1:p.Met1677Thr
  • NP_001340886.1:p.Met1661Thr
  • NP_001340887.1:p.Met1661Thr
  • NP_001340889.1:p.Met1660Thr
  • NP_001340890.1:p.Met875Thr
  • NP_008851.3:p.Met1678Thr
  • LRG_8:g.86431T>C
  • NC_000002.11:g.166848719A>G
  • NM_001165963.1:c.5066T>C
  • NM_001165963.2:c.5066T>C
  • NR_148667.2:n.5483T>C
Protein change:
Molecular consequence:
  • NM_001165963.4:c.5066T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001165964.3:c.4982T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001202435.3:c.5066T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353948.2:c.5066T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353949.2:c.5033T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353950.2:c.5033T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353951.2:c.5033T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353952.2:c.5033T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353954.2:c.5030T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353955.2:c.5030T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353957.2:c.4982T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353958.2:c.4982T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353960.2:c.4979T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001353961.2:c.2624T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_006920.6:c.5033T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NR_148667.2:n.5483T>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]


Early infantile epileptic encephalopathy with suppression bursts (EIEE)
Early infantile epileptic encephalopathy; Ohtahara syndrome; Developmental and epileptic encephalopathy
MONDO: MONDO:0100062; MedGen: C0393706; Orphanet: 1934; OMIM: PS308350

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
SCV001388559Invitaecriteria provided, single submitter
Uncertain significance
(Sep 1, 2021)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing



Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]

Details of each submission

From Invitae, SCV001388559.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)


This sequence change replaces methionine with threonine at codon 1689 of the SCN1A protein (p.Met1689Thr). The methionine residue is highly conserved and there is a moderate physicochemical difference between methionine and threonine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals affected with SCN1A-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 7, 2023